Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

823446

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to increase the supply of flu vaccines to areas in the event that there are shortfalls of such vaccines during Winter 2017-18.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	122924
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>Flu vaccines for people aged 18 years and older are procured directly from manufacturers and suppliers by providers. The procurement and distribution of flu vaccines for the children’s aspect of the national flu programme is managed by Public Health England.</p><p> </p><p>Flu vaccine remains available to order from manufacturers and suppliers across England for both the adult and the children’s aspects of the national flu immunisation programme.</p><p> </p><p>Officials are continuously monitoring the flu vaccine supply landscape to enable timely and appropriate action to be taken in the event that demand begins to outweigh the amount of flu vaccine that is currently available to patients.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 122923 question first answered 24/01/2018 11:59:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

823445

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the availability of stocks of flu vaccines in (a) York and (b) England.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	122923
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>Flu vaccines for people aged 18 years and older are procured directly from manufacturers and suppliers by providers. The procurement and distribution of flu vaccines for the children’s aspect of the national flu programme is managed by Public Health England.</p><p> </p><p>Flu vaccine remains available to order from manufacturers and suppliers across England for both the adult and the children’s aspects of the national flu immunisation programme.</p><p> </p><p>Officials are continuously monitoring the flu vaccine supply landscape to enable timely and appropriate action to be taken in the event that demand begins to outweigh the amount of flu vaccine that is currently available to patients.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 122924 question first answered 24/01/2018 11:59:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

823588

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an estimate of the average yearly cost to patients of paying for prescribed asthma medication.
	tabling member constituency	Warrington North
	tabling member printed	Helen Jones
	uin	123051
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>The Department has made no such estimate. FP10 prescriptions forms do not specify what clinical indication the medicine/device is being prescribed for, therefore the requested data is not collected.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/01/2018 12:15:06 answering member 4067 label Biography information for Steve Brine
	tabling member	432 label Biography information for Helen Jones

823373

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with GPs and clinical bodies on improving the rate at which diabetics take their medications.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	122856
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>The appropriate use of prescribed medication for diabetes, and any actions to support this, can form part of the annual reviews between general practitioners and their diabetes patients. NHS England is also overseeing the investment of diabetes transformation funding towards improved access to diabetes structured education within individual clinical commissioning groups.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/01/2018 12:02:40 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

823372

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ovarian Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the introduction of new medicines to help prevent the spread of ovarian cancer.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	122855
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) has published a number of technology appraisal guidance documents on the treatment of ovarian cancer. NICE technology appraisal guidance makes recommendations for the National Health Service on whether drugs and treatments represent a clinically and cost effective use of resources. NHS commissioners are legally required to fund drugs and treatments recommended through the technology appraisal programme within three months.</p><p> </p><p>NICE has positively appraised guidance on use of “Paclitaxel in the treatment of ovarian cancer” (TA:55), published in May 2005; “Olaparib for maintenance treatment of relapsed, platinum-sensitive, BRCA mutation-positive ovarian, fallopian tube and peritoneal cancer after response to second-line or subsequent platinum-based chemotherapy” (TA:381), published in January 2016; and, “Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer” (TA:389), published in April 2016.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/01/2018 12:11:27 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

823518

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Life Sciences
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps are being taken to ensure that the UK enters the top quartile of comparator countries for the speed of adoption and overall uptake of innovative treatments as recommended in the Life Sciences Industrial Strategy.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	122988
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>Comparisons of uptake of medicines between different countries with different health systems are difficult and should be treated with caution. However, we are committed to working with industry on this issue and share the ambition to maximise the appropriate use of innovation in our system and tackle unwarranted variation in uptake. The Government and industry are currently working together through a series of workshops that will provide the foundation for the next medicines pricing scheme, and discussions around uptake, adoption and metrics have been a feature of those early meetings.</p><p> </p><p>The recent Government and partner bodies response to the Accelerated Access Review sets out how we will work with industry and the health system to create a streamlined and sophisticated approvals system so that cost-effective breakthrough products – be they drugs, devices, digital or diagnostics – can get into the National Health Service as fast as possible.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/01/2018 11:57:48 answering member 4067 label Biography information for Steve Brine
	tabling member	104 label Biography information for Crispin Blunt

823522

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Life Sciences
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps are being taken to update and evolve value assessments of drugs, medical devices and diagnostics, as recommended in the Life Sciences Industrial Strategy.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	122991
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) is committed to playing its part in delivering the vision set out in the Life Sciences Industrial Strategy. Ensuring that appraisals are fit for purpose in a fast-changing sector is critical. NICE has recently taken steps to do this by introducing changes to its processes to support faster access to the most effective treatments, while addressing affordability issues. In addition, NICE has recently consulted on further changes to streamline its technology appraisal processes so that it is better able to develop new guidance on innovative drugs and medical technologies.</p><p> </p><p>As set out in the response to the Accelerated Access Review, we are also introducing a new Accelerated Access Pathway, to streamline regulatory and market access decisions for a small number of products, getting breakthrough products that we believe will be truly transformative to patients even more quickly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/01/2018 16:38:26 answering member 4067 label Biography information for Steve Brine
	tabling member	104 label Biography information for Crispin Blunt

823523

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the extension of Orkambi's licence to treat patients aged six and over, what support his Department is giving to further negotiations among NICE, NHS England and the drug manufacturer, Vertex, on access to that medicine for people with cystic fibrosis.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	122992
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>The Department wants patients with cystic fibrosis to benefit from clinically and cost effective treatments, and we welcome the on-going dialogue between Vertex and NHS England to pursue a deal that would make Orkambi available to National Health Service patients.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/01/2018 12:13:27 answering member 4067 label Biography information for Steve Brine
	tabling member	104 label Biography information for Crispin Blunt

823664

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pneumococcal Diseases: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to ensure adequate supplies of the PPV23 vaccine.
	tabling member constituency	Colne Valley
	tabling member printed	Thelma Walker
	uin	123119
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>The Department is aware of the intermittent issues affecting the supply of Pneumococcal polysaccharide 23-valent vaccine (PPV 23 vaccine). We are working closely with Public Health England (PHE) and the supplier, MSD, on this issue and can confirm that further United Kingdom deliveries are expected to be made available over the coming months. Despite this, supplies are expected to be constrained for the foreseeable future. In order to mitigate the impact to patients, PHE has issued clinical guidance to general practitioners, which provides recommendations on how to manage patients who are eligible for vaccination during periods of constraint.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/01/2018 12:04:59 answering member 4067 label Biography information for Steve Brine
	tabling member	4649 label Biography information for Thelma Walker

823743

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Huntington's Disease: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many prescriptions of (a) individual benzodiazepine drugs and (b) individual antidepressants were dispensed in the community in 2016.
	tabling member constituency	Bristol North West
	tabling member printed	Darren Jones
	uin	123187
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>The information requested can be found in the attached table.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/01/2018 12:08:27 answering member 4067 label Biography information for Steve Brine attachment 1 file name PQ123187 table.docx title PQ123187 attached table
	tabling member	4621 label Biography information for Darren Jones